Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFAMIDIS vs TAFLUPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TAFAMIDIS vs TAFLUPROST: Safety Overview

Metric TAFAMIDIS TAFLUPROST
Total FAERS Reports 9,202 1,677
Deaths Reported 3,343 282
Death Rate 36.3% 16.8%
Hospitalizations 2,284 75
Average Patient Age 80.7 yrs 76.0 yrs
% Female Patients 20.7% 73.5%
FDA Approval Date May 3, 2019 Apr 5, 2024
Manufacturer Pfizer Laboratories Div Pfizer Inc Micro Labs Limited
Route N/A OPHTHALMIC
Marketing Status Prescription Prescription